Shares outstanding · 2017–2025
Ascendis Pharma shares outstanding
62.0M+2.1% · FY2025
Ascendis Pharma (ASND) reported 62.0M in shares outstanding for fiscal 2025, +2.1% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 62.0M | +2.1% | Open → |
| FY20242024-12-31 | 60.7M | +5.2% | Open → |
| FY20232023-12-31 | 57.7M | +1.0% | Open → |
| FY20222022-12-31 | 57.2M | +0.4% | Open → |
| FY20212021-12-31 | 56.9M | +5.9% | Open → |
| FY20202020-12-31 | 53.8M | +12.0% | Open → |
| FY20192019-12-31 | 48.0M | +13.9% | Open → |
| FY20182018-12-31 | 42.1M | +13.9% | Open → |
| FY20172017-12-31 | 37.0M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +6.7%
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ascendis Pharma shares outstanding |url=https://companiesranked.com/en/company/ascendis-pharma/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ascendis Pharma shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/shares-outstandingBibTeX
@misc{companiesranked-en-company-ascendis-pharma-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Ascendis Pharma shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026
{{cite web |title=Ascendis Pharma shares outstanding — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.